Extending patent protections to discover the next life-saving drugs
At the end of last year, Eli Lilly’s mega-blockbuster antidepressant Cymbalta went off patent. And Cymbalta’s generic version, known as duloxetine, rushes in the market and drives down the price, making it more affordable.